Kepler AI builds an AI agent platform for bioinformatics research and workflow automation. It lets research teams, biotech firms, and pharmaceutical companies ask complex questions in plain English without writing code, and it connects to large datasets to speed up drug discovery. The platform supports data analysis, experiment planning, and literature reviews by running AI agent-based queries across integrated data sources, unifying scattered databases to help identify drug candidates more efficiently. A notable collaboration with TileDB and Tahoe Therapeutics produced TahoeDive, which adds Tahoe-100M single-cell perturbation data into Kepler AI’s platform. The company’s goal is to increase scientific productivity and accuracy in life sciences R&D and to accelerate the path from data to actionable insights in drug discovery.
Company Size
1-10
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2025
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?